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ABSTRACT
Asthma accounts for an estimated 3 million workdays lost each year in the United States in
addition to reduced worker productivity. Although asthma disease management programs are
relatively common in managed care organizations, they have generally not been offered at
the workplace. Seventy-six employees participated in a five-session worksite-based asthma
education program. A total of 47 of 76 (61.8%) employees completed baseline and 12-month
follow-up Asthma Therapy Assessment Questionnaires (ATAQ). The ATAQ includes mea-
surement of poor asthma control, behavior/attitude barriers, knowledge barriers, patient/
provider communication barriers, and efficiency. Significant improvement was noted in mea-
sures of asthma control (p , 0.05), communication (p , 0.005), knowledge (p , 0.001), and the
total ATAQ Index declined from 5.53 to 4.04 (p , 0.001). Employee satisfaction results for the
program were exceptionally high. A worksite-based asthma education program should reduce
medical care costs, worker absenteeism, and improve worker productivity. The worksite can
be a very effective location for disease education programs.
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INTRODUCTION
ASTHMA AFFECTS more than 10 million Amer-ican adults and is one of the leading causes
of lost productivity at school and at work.1 It
accounts for an estimated 3 million workdays
lost annually in the United States, and over $1
billion is spent each year on healthcare for
asthma alone.
In 1997, more than 30.5 million prescriptions
for asthma medications were filled. In addition,
there were approximately 1.2 million emer-
gency room visits and 445,000 hospital inpa-
tient days attributable to acute asthmatic at-
tacks.2 In 1994, 14.6 million individuals (56.1
per 1,000) reported having attacks of asthma
during the preceding 12 months, a self-re-
ported prevalence that was 75% greater than
the comparable figure for 1980.3 Despite the in-
creasing availability of effective treatments for
asthmatic attacks, the numbers of asthma-re-
lated hospitalizations and deaths have been 
rising.4
According to Musich et al., the total cost of
asthma in 1997 dollars was $15.1 billion, in-
cluding $11.8 billion in direct costs and $3.3 bil-
lion to indirect costs.5 The National Heart,
Lung, and Blood Institute found that inpatient
hospitalizations accounted for 45% of the direct
expenditures, and the cost of drugs accounted
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for approximately 30% of the total cost.6 The
average annual cost for treating a single asth-
matic patient in 1995 was estimated to range
from $2,584 to $5,710.7
Asthma is a controllable disease; however,
control cannot be accomplished without pa-
tient education and involvement in a planned
disease management strategy. An example of
this strategy is the asthma guidelines devel-
oped by a panel of experts convened by the Na-
tional Heart, Lung, and Blood Institute.8
Many studies demonstrate the value of pa-
tient education and disease management in
asthmatics. Evidenced-based disease manage-
ment interventions have reduced healthcare
costs in patients with asthma. Gaioni et al. stud-
ied a cohort of 207 patients 1 year after they
had completed a disease management program
at an asthma center.9 The patients showed a
78% reduction in hospitalization, a 73% reduc-
tion in emergency department visits, and a 48%
reduction in unscheduled physician visits.
Overall net savings were estimated to average
$2,714 per patient per year. Patients’ knowl-
edge of self-care test scores for asthma in-
creased from 48% to 96%.9
There have been numerous reports docu-
menting the beneficial effects of increasing a
patients’ knowledge of asthma self-manage-
ment. Kotses et al., demonstrated that soon af-
ter a 7-week asthma education program, pa-
tients showed improvement in asthma
management skills and cognitive abilities, had
fewer asthma symptoms, and experienced a re-
duction in physician visits.10 At the end of 1
year, in comparison with a control group re-
ceiving routine care, program participants had
fewer asthmatic attacks, reduced use of med-
ications, showed improvement in cognitive
measures, and increased reliance on self-man-
agement skills.10 Zimmer et al. evaluated the
results of a year-long, in-home, telephonic ed-
ucation and training program in a group of 40
adults considered to have moderate, severe, or
uncontrolled asthma. The participants reported
a decrease in absenteeism and fewer days of re-
duced productivity.11
Similarly, Snyder et al. randomly assigned 79
adult asthmatics to a waiting list or to a pro-
gram of training in self-management and found
that as knowledge about asthma control in-
creased in the study group compared to the
controls, the number of asthmatic attacks de-
creased.12
Finally, Soucy and Siderov studied 312 asth-
matics among the members of a group-model
health maintenance organization who enrolled
in an asthma disease management program.
One year later, the average cost of claims for
asthma treatment had decreased from $28 per
member per month to $20 per member per
month.13
Despite such well-documented demonstra-
tions of the value of health education programs
in the management of asthma, many patients
are not receiving them. Reasons for the lack of
availability of asthma disease management
programs include nonreimbursable services,
insufficient numbers of asthmatics in a medical
practice, and lack of a trained nursing or health
educator to conduct the program.
Patients must also accept responsibility for
the management of a chronic disease such as
asthma. They need to appreciate the potential
value of disease management and devote time
to educational programs. Although asthma ed-
ucation and disease management programs
may be offered in the healthcare setting, they
may be offered during working hours when
employed asthmatics, already plagued by ab-
sences caused by acute attacks, may be reluc-
tant to take more time from work.
The objective of this study was to evaluate a
worksite-based education program targeted at
employees with nonoccupational asthma. This
was a relatively low-cost program to improve
control of asthma in workers.
METHOD
Bank One, created in October 1988 by the
merger of the First Chicago NBD Corporation
(FCNBD) and Banc One, is the fourth largest
U.S. bank holding corporation. It has over
80,000 employees. In September 1998, 1 month
before the merger, the FCNBD Medical De-
partment offered a worksite-based program
called the “FirstAir Asthma Education Pro-
gram” to the 12,000 employees at its downtown
Chicago location. The objectives of this pro-
gram were previously described: they included
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education of asthmatic employees on the value
and importance of optimal management and to
train them in the elements of self-care.14 The in-
centive to the employer was the prospect of in-
creased productivity reflecting a potential
diminution in absences and impaired work
performance, enhanced employee morale, and
a decrease in medical claims.
The FirstAir Asthma Education Program
The program consisted of five weekly 1-hour
sessions during the lunch hour. The sessions
were conducted by a well-trained clinical
asthma nurse specialist and covered such top-
ics as symptoms of asthma, recognition of trig-
gers and warning signs of asthmatic attacks,
medications and other treatments for asthma,
use and care of peak flow meters, nebulizers
and metered-dose inhalers, handling emergen-
cies, and how to keep an asthma diary (see
Table 1).
Incentives were offered to encourage com-
pletion of the program. They included a free
healthy lunch at every session; a free 1-year
subscription to Asthma Magazine ($22 retail); a
wellness tote bag filled with educational mate-
rials such as keeping an asthma-friendly home
environment; a copy of How to Outsmart Your
Allergies; a popular book by Art Ulene, M.D.,
the well-known television commentator on
health topics; and a drawing for a number of
items useful for asthmatics such as a cold
weather mask, a pillow protector, and an in-
haler cover. In addition, those who completed
a health questionnaire focused on asthma were
given a $25 gift certificate. Prior to entering the
program, each participant completed a com-
puterized health risk appraisal that, in addition
to behavioral and other health information, in-
cluded measurements of blood pressure, serum
cholesterol, and height and weight to calculate
body mass index.
Employees with asthma were identified by
using Bank One’s integrated health data ware-
house, nicknamed OMNI (Occupational Med-
ical and Nursing Information).15 The confiden-
tial database, access to which is limited to the
Medical Department staff, includes health in-
surance claims (inpatient, outpatient, and phar-
macy), short-term disability absences, and a
computer-based medical record. Claims bear-
ing ICD-9 (International Classification of Dis-
eases) diagnostic codes relating to asthma were
used. An occupational health nurse, trained in
the program’s objectives and content, inter-
viewed each of these individuals and invited
them to participate. In addition, information re-
garding the program along with an invitation
to participate was sent to each of the 12,000
Bank One employees working in downtown
Chicago. In all, 76 participants signed up for
the program.
The instrument used to evaluate the effec-
tiveness of the FirstAir program was the
Asthma Therapy Assessment Questionnaire
(ATAQ) developed and distributed by Merck
& Company, Inc. [West Point, PA, (Fig. 1)]. The
ATAQ measures an individual’s self-reported
severity of asthma symptoms, medication com-
pliance barriers, deficiency in knowledge of
asthma, and barriers to effective communica-
tion with his or her healthcare provider.16,17
Participants were asked to complete the ATAQ
at baseline, at the end of the 2-month program,
and 4 and 12 months following completion of
the program. At the same time, participants
were asked to report any absences from work
during the prior period.
Responses to the ATAQ surveys were
summed to produce scores on the following
asthma disease management issues: asthma
control, behavior/attitude barriers, knowledge
barriers, communication barriers, and self-effi-
cacy issues. The University of Michigan Health
Management Research Center independently
scored and analyzed the responses. Each par-
ticipant received a personal letter describing
his or her individual specific risk indicators and
suggesting particular recommendations for im-
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TABLE 1. CURRICULUM OF THE
ASTHMA EDUCATION PROGRAM
Session number Topics covered
One Understanding asthma




Five Putting it all together: questions
and answers
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FIG. 1. Asthma Therapy Assessment Questionnaire (ATAQ). Reprinted with permission from Merck & Company, Inc.
proving asthma self-management skills. Partic-
ipants were urged to discuss the content of this
letter with their personal physicians.
Poor asthma control is defined by the ATAQ
as the presence of nocturnal awakenings due
to respiratory difficulties, days of absence or in-
ability to perform usual activities, increased
use of beta-agonists, and exercise-induced
symptoms since the last ATAQ survey.
Behavior/attitude barriers evaluated the em-
ployee’s satisfaction with the treatment plan,
the medications prescribed, and the healthcare
in general. Questions also addressed potential
compliance with the regimen of medications
prescribed such as failure to use controller/
prevention medications or overuse of reliever/
rescue medications.
The measure of self-efficacy on the ATAQ
probed the individual’s personal beliefs and at-
titudes relating to asthma, the medications pre-
scribed, and the resources available to manage
the disease.
ATAQ questions relating to patient/
provider communication barriers explore the
patients’ desire, willingness, and ability to
communicate with their healthcare provider
about asthma symptoms and responses to
treatment during routine follow-up or other of-
fice visits. They also assess whether or not the
patient has the resources needed to assist in
self-management of the disease such as a spe-
cial asthma action plan.
ATAQ questions on knowledge barriers
test patients’ understanding of the proper use
of their medications, what they are intended
to do, and when and how often they should
be used, including the continued use of con-
troller medications to prevent recurrent at-
tacks.
Employee demographics
The program began with 76 participants.
Their mean age was 39.3 years (range, 23 to 69
years), with 83.1% females and 16.9% males.
Ethnicity was 50.6% Caucasian, 29.8% African
American, 10.4% Asian, 7.8% Hispanic, and
1.3% unknown. Demographics of participants
in the asthma education program did not dif-
fer significantly from the overall bank popula-
tion demographics.
Results of the ATAQ survey
Of the 76 employees who began in the pro-
gram, 68 returned completed ATAQ question-
naires after 2 months, 53 completed the 4-
month follow-up, and 47 completed the final
questionnaire at 12 months. Forty-one partici-
pants (53.9%) completed all four ATAQ ques-
tionnaires. They did not differ significantly in
the demographic variables (age, gender, and
ethnicity) from the original cohort of 76. Figure
2 shows the ATAQ scores for 47 participants
who completed both a baseline and 12-month
follow-up questionnaire.
There was a statistically significant (p , 0.05)
improvement in ATAQ scores for control, com-
munication, knowledge, and the total ATAQ
index. No statistically significant change was
found for behavior and self-efficacy ATAQ
scores.
Control barriers
The control barrier score is the sum of re-
sponses to four questions regarding (1) poor
asthma control, (2) absences from school or
work or uncompleted activities, (3) nocturnal
awakening because of asthma, and (4) overuse
or increased use of reliever medications. The
score may range from 0 to 4. The mean score
for control barriers showed a positive trend, de-
clining from 1.83 at baseline to 1.28 at 12
months (see Fig. 2).
The number of employees who reported no
control barriers increased from 11% at baseline
to 28% after 4 months (p , 0.01). The number
of employees who reported all four control bar-
riers decreased from 7% at baseline to 0% at 4
months (p , 0.01). These scores were main-
tained at the 12-month follow-up.
Medication usage is an important factor in
asthma control. Figure 3 shows the distribution
of medication usage at baseline and 12-month
follow-up. Statistically significant (p , 0.05)
improvement was noted in the number of par-
ticipants reporting use of an asthma controller
medication on a daily basis.
Communication barriers
The communication barriers score is derived
from the responses to five questions regarding
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(1) patient and provider review of medications,
(2) patient and provider share in making of
therapy decisions, (3) written action/treatment
plans for exacerbations, (4) routine manage-
ment recommendations developed jointly by
patient and provider, and (5) provider being
aware of patient’s preferences for therapy. The
score may range from 0 to 5. The number of
participants with a written treatment control
plan increased significantly from baseline to
the 12-month follow-up. The Merck communi-
cation score decreased from 2.77 at baseline to
2.15 at 12 months (p , 0.05). Reviewing med-
ications with the physician, making decisions
jointly with the physician, and having treat-
ment preferences known to the physician re-
mained consistently high throughout the study
period. Having a written treatment plan for
acute asthma attacks (in contrast to asthma con-
trol) increased from 10% to 17% of participants
(p, not significant).
Knowledge barriers
The knowledge barriers were evaluated by
the yes/no responses to: (1) patient doesn’t
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FIG. 2. Asthma Therapy Assessment Questionnaire (ATAQ) scores at baseline and 12-month follow-up (n 5 47).
*p , 0.05. **p , 0.001.
FIG. 3. Asthma medication usage before and after completion of the FirstAir Asthma Education Program (n 5 47).
p , 0.05.
know if a tablet and/or inhalant has been pre-
scribed for the relief of symptoms, (2) patient
doesn’t know if a pill and/or inhalant has been
prescribed for asthma control, and (3) patient
reports that the asthma was well controlled
during the past month yet overused reliever
medication. Very few employees reported hav-
ing more than one knowledge deficit. The mean
knowledge barrier score declined from 0.21 at
baseline to 0.07 at 12 months (p , 0.001).
Behavior barriers
There were two attitude/behavior barriers:
(1) Is the patient dissatisfied with his/her cur-
rent asthma treatment? And (2) A controller
medication has been prescribed but the patient
is not using it every day. The average behav-
ior barrier score declined from 0.49 at baseline
to 0.45 at the 12-month follow-up.
The number of employees reporting dissat-
isfaction with their current asthma treatment
remained low from baseline through the fol-
low-up. Significant changes were seen, how-
ever, in the use of controller medications. The
number of participants who reported having a
prescription for controller medication in-
creased from 59% at baseline to 76% at the 12-
month follow-up (p , 0.05).
Self-efficacy barriers
The self-efficacy barriers included: (1)
whether the respondents believe that they were
able to take their medications as directed and
(2) whether they believe that their medications
are useful in the treatment of their attacks (see
Fig. 2). Self-efficacy barriers were low at base-
line (98% reported being able to take their med-
ications as directed, and 80% believed their
medications to be useful). This is not surpris-
ing when one considers the education levels of
these employee participants. Nevertheless, the
mean self-efficacy scores declined from 0.23 at
baseline to 0.12 at the 12-month follow-up, in-
dicating that improvement was still possible.
Overall ATAQ Index of disease management
The total barrier index is the sum of the five
ATAQ disease management barrier scores. The
number of participants reporting no barriers in
each of these domains increased at the 4-month
follow-up. The average total barrier index re-
ported at baseline was 5.53; it decreased  to 4.04
at the end of 1 year (p , 0.05) (see Fig. 2). This
consistent trend toward improvement demon-
strates that the participants retained the posi-
tive effects of the educational program for at
least a year and probably longer.
Program satisfaction
Sixty-two participants (79.8%) completed a
program evaluation survey at the conclusion of
the FirstAir Asthma Education Program. Re-
sults (see Table 2) show that 95% of participants
rated the program as excellent or very good.
Almost 80% rated the instructor as excellent or
very good, and 84% gave high marks for the
written materials. Seventy-three percent of par-
ticipants noted they would take steps to reduce
known asthma triggers, a large part of control-
ling asthma and preventing attacks, as a result
of the educational program. Of those who re-
ported seeing a doctor since the program, 33%
claimed the program significantly promoted
communication with their physician.
DISCUSSION
Asthma affects approximately 6.8% of the
Bank One employee population. This is similar
to the prevalence reported in the adult U.S.
population. In addition to direct healthcare
costs, employees may have significant lost on-
the-job productivity and absences from work if
asthma is not controlled. A population ap-
proach to the management of common chronic
diseases in the workplace has already been
demonstrated to be effective in managed care
organizations. Buchner et al. studied 2,734
adult asthmatics in a 500,000-member managed
care organization.18 The asthma health man-
agement program provided education on the
National Heart, Lung, and Blood Institute
guidelines for the treatment of asthma to physi-
cians as well as providing educational “kits”
for patients with asthma. Asthmatic patients re-
ported significant improvement in receiving in-
structions for a flare-up of their asthma. The
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proportion of asthmatics in the populations
with one or more inpatient hospitalizations de-
clined from 5.6% to 4.6% (p , 0.01).
This study demonstrates that significant im-
provement in asthma control as measured by
the ATAQ questionnaire is possible with a
worksite-based asthma disease education pro-
gram. Significant improvement was noted in
the measures of asthma control, communica-
tion, knowledge, and a total index of asthma
management. Employees with asthma had sta-
tistically significant improvement in ATAQ
scores at 2 months from the beginning of the
program and retained the positive effects of the
educational intervention for at least 1 year af-
ter the program.
An important measure of asthma disease
management is the use of controller medica-
tions to prevent an acute asthma attack in place
of a reliever medication used to respond to an
acute attack of asthma. This was associated
with a reduction in nighttime awakenings and
missed work.
Workplace-based disease management pro-
grams for employees are intended to supple-
ment and enhance the education provided by
the employee’s healthcare provider. Improved
asthma control has potential benefits for the
employee, employer, and healthcare provider.
Reduced medical costs will benefit the em-
ployer and health plan. The employee benefits
from improved quality of life, reduced out-of-
pocket medical costs, and any lost wages from
absenteeism. The employer benefits from re-
duced medical and disability costs and im-
proved worker productivity.
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TABLE 2. AGGREGATED RESULTS FROM PROGRAM EVALUATION SURVEYS
COMPLETED BY EMPLOYEES AT THE CONCLUSION OF THE PROGRAM
n Percentage
Rating of the FirstAir program
Excellent 47 76




Rating of the instructor
Excellent 46 74





Rating of the written materials
Excellent 39 64




As a result of the FirstAir Program, participants will:
Visit doctor more regularly 20 32
Take medication properly and consistently 37 60
Take steps to reduce known triggers 45 73
Develop written treatment plan with doctor 26 42
Program promoted communication with doctora
Significantly 18 33
Some 20 37
Little/no change 16 30
aThirty-six (58%) also reported they had not visited their doctors at the time
of the postprogram (2 months) survey.
CONCLUSION
It has been demonstrated that disease man-
agement strategies that focus on both control
and prevention of acute asthmatic attacks re-
sult in fewer attacks, improved well-being, en-
hanced work performance, greater productiv-
ity, and reduced healthcare costs. In fact,
asthma and diabetes have been declared to be
prime examples of diseases in which the key
elements of disease management may be stud-
ied and tested.19,20 These elements include pa-
tient understanding of the disease and its treat-
ment, enhanced communication between the
patient and his/her healthcare provider, and
optimal utilization of self-care. They are ap-
proached through a properly designed and ef-
fectively delivered asthma education program.
Unfortunately, even where effective asthma ed-
ucation programs exist in the community, asth-
matics do not have access to, or fail to take ad-
vantage of, them.
The FirstAir Asthma Education Program de-
scribed in this article demonstrates how this de-
ficiency may be met through a relatively sim-
ple, low-cost, voluntary program provided in
the worksite to employees with asthma. This
program properly leaves command of disease
management in the hands of the employees’
personal physicians. It focuses on education of
the employee in knowledge of the disease and
its treatment, training in self-care, and how to
hold up his/her end in the obligatory collabo-
ration with the healthcare provider.
This study also demonstrates the utility of
ATAQ as an instrument for evaluating the bar-
riers to effective asthma management and how
these barriers are diminished or removed by
the asthma education program. ATAQ may
also be used in more extended follow-ups to
test the persistence of the successes of the pro-
gram as well as the need to repeat the program
due to new asthmatic employees arriving as a
result of turnover in or expansion of the work-
force.
Finally, although not directly measured, it
may be inferred from the data presented herein
that the modest cost of the program to the em-
ployer was more than matched by the mone-
tary value of the gains in employee well being
and productivity.
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